Bristol-Myers Squibb Company Ce (CELG-RI)
USD 0.04
(-11.76%)
USD 0.04
(-11.76%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 8.02 Billion USD | 26.84% |
| 2022 | 6.32 Billion USD | -9.54% |
| 2021 | 6.99 Billion USD | 177.75% |
| 2020 | -8.99 Billion USD | -361.56% |
| 2019 | 3.43 Billion USD | -30.55% |
| 2018 | 4.95 Billion USD | 391.76% |
| 2017 | 1 Billion USD | -77.41% |
| 2016 | 4.45 Billion USD | 174.45% |
| 2015 | 1.62 Billion USD | -18.96% |
| 2014 | 2 Billion USD | -21.81% |
| 2013 | 2.56 Billion USD | 30.77% |
| 2012 | 1.96 Billion USD | -47.16% |
| 2011 | 3.7 Billion USD | 19.57% |
| 2010 | 3.1 Billion USD | -70.77% |
| 2009 | 10.61 Billion USD | 102.25% |
| 2008 | 5.24 Billion USD | 142.36% |
| 2007 | 2.16 Billion USD | 36.59% |
| 2006 | 1.58 Billion USD | -47.17% |
| 2005 | 3 Billion USD | 25.63% |
| 2004 | 2.38 Billion USD | -23.12% |
| 2003 | 3.1 Billion USD | 50.34% |
| 2002 | 2.06 Billion USD | -60.61% |
| 2001 | 5.24 Billion USD | 11.34% |
| 2000 | 4.71 Billion USD | 13.05% |
| 1999 | 4.16 Billion USD | 32.66% |
| 1998 | 3.14 Billion USD | -2.0% |
| 1997 | 3.2 Billion USD | 12.46% |
| 1996 | 2.85 Billion USD | 57.28% |
| 1995 | 1.81 Billion USD | -1.63% |
| 1994 | 1.84 Billion USD | -5.97% |
| 1993 | 1.95 Billion USD | -0.15% |
| 1992 | 1.96 Billion USD | -4.57% |
| 1991 | 2.05 Billion USD | 17.62% |
| 1990 | 1.74 Billion USD | 134.0% |
| 1989 | 747 Million USD | -40.43% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | 1.21 Billion USD | -27.92% |
| 2024 Q2 | 1.68 Billion USD | 114.1% |
| 2024 Q1 | -11.91 Billion USD | -775.99% |
| 2023 FY | 8.02 Billion USD | 26.84% |
| 2023 Q2 | 2.07 Billion USD | -8.36% |
| 2023 Q1 | 2.26 Billion USD | 11.87% |
| 2023 Q4 | 1.76 Billion USD | -8.61% |
| 2023 Q3 | 1.92 Billion USD | -6.99% |
| 2022 Q1 | 1.27 Billion USD | -46.12% |
| 2022 Q4 | 2.02 Billion USD | 25.9% |
| 2022 FY | 6.32 Billion USD | -9.54% |
| 2022 Q3 | 1.6 Billion USD | 13.02% |
| 2022 Q2 | 1.42 Billion USD | 11.19% |
| 2021 FY | 6.99 Billion USD | 177.75% |
| 2021 Q1 | 2.02 Billion USD | 120.16% |
| 2021 Q3 | 1.54 Billion USD | 46.54% |
| 2021 Q4 | 2.37 Billion USD | 53.43% |
| 2021 Q2 | 1.05 Billion USD | -47.8% |
| 2020 Q1 | -775 Million USD | 26.61% |
| 2020 Q2 | -85 Million USD | 89.03% |
| 2020 Q3 | 1.87 Billion USD | 2302.35% |
| 2020 FY | -8.99 Billion USD | -361.56% |
| 2020 Q4 | -10.02 Billion USD | -635.63% |
| 2019 FY | 3.43 Billion USD | -30.55% |
| 2019 Q1 | 1.71 Billion USD | 43.46% |
| 2019 Q2 | 1.43 Billion USD | -16.26% |
| 2019 Q4 | -1.05 Billion USD | -178.05% |
| 2019 Q3 | 1.35 Billion USD | -5.52% |
| 2018 FY | 4.95 Billion USD | 391.76% |
| 2018 Q4 | 1.19 Billion USD | -37.3% |
| 2018 Q3 | 1.9 Billion USD | 409.65% |
| 2018 Q2 | 373 Million USD | -74.9% |
| 2018 Q1 | 1.48 Billion USD | 163.83% |
| 2017 Q2 | 916 Million USD | -41.8% |
| 2017 FY | 1 Billion USD | -77.41% |
| 2017 Q4 | -2.32 Billion USD | -375.5% |
| 2017 Q3 | 845 Million USD | -7.75% |
| 2017 Q1 | 1.57 Billion USD | 76.06% |
| 2016 Q2 | 1.16 Billion USD | -2.43% |
| 2016 Q1 | 1.19 Billion USD | 965.94% |
| 2016 FY | 4.45 Billion USD | 174.45% |
| 2016 Q4 | 894 Million USD | -25.62% |
| 2016 Q3 | 1.2 Billion USD | 3.09% |
| 2015 Q2 | -130 Million USD | -110.96% |
| 2015 Q4 | -138 Million USD | -119.55% |
| 2015 Q3 | 706 Million USD | 643.08% |
| 2015 Q1 | 1.18 Billion USD | 9023.08% |
| 2015 FY | 1.62 Billion USD | -18.96% |
| 2014 FY | 2 Billion USD | -21.81% |
| 2014 Q4 | 13 Million USD | -98.2% |
| 2014 Q3 | 721 Million USD | 116.52% |
| 2014 Q2 | 333 Million USD | -64.46% |
| 2014 Q1 | 937 Million USD | 29.06% |
| 2013 Q2 | 536 Million USD | -11.99% |
| 2013 Q3 | 692 Million USD | 29.1% |
| 2013 Q4 | 726 Million USD | 4.91% |
| 2013 FY | 2.56 Billion USD | 30.77% |
| 2013 Q1 | 609 Million USD | -34.16% |
| 2012 Q3 | -711 Million USD | -210.23% |
| 2012 Q2 | 645 Million USD | -41.42% |
| 2012 Q1 | 1.1 Billion USD | 29.23% |
| 2012 FY | 1.96 Billion USD | -47.16% |
| 2012 Q4 | 925 Million USD | 230.1% |
| 2011 Q3 | 969 Million USD | 7.43% |
| 2011 Q2 | 902 Million USD | -8.52% |
| 2011 Q1 | 986 Million USD | 104.14% |
| 2011 FY | 3.7 Billion USD | 19.57% |
| 2011 Q4 | 852 Million USD | -12.07% |
| 2010 Q4 | 483 Million USD | -49.1% |
| 2010 Q2 | 927 Million USD | 24.76% |
| 2010 FY | 3.1 Billion USD | -70.77% |
| 2010 Q1 | 743 Million USD | -90.74% |
| 2010 Q3 | 949 Million USD | 2.37% |
| 2009 Q1 | 638 Million USD | -48.71% |
| 2009 Q2 | 1.29 Billion USD | 103.45% |
| 2009 Q3 | 966 Million USD | -25.58% |
| 2009 Q4 | 8.02 Billion USD | 730.75% |
| 2009 FY | 10.61 Billion USD | 102.25% |
| 2008 Q1 | 661 Million USD | 842.7% |
| 2008 Q3 | 2.57 Billion USD | 237.43% |
| 2008 FY | 5.24 Billion USD | 142.36% |
| 2008 Q4 | 1.24 Billion USD | -51.75% |
| 2008 Q2 | 764 Million USD | 15.58% |
| 2007 Q3 | 858 Million USD | 21.53% |
| 2007 FY | 2.16 Billion USD | 36.59% |
| 2007 Q4 | -89 Million USD | -110.37% |
| 2007 Q2 | 706 Million USD | 2.32% |
| 2007 Q1 | 690 Million USD | 614.93% |
| 2006 Q1 | 714 Million USD | 43.09% |
| 2006 FY | 1.58 Billion USD | -47.17% |
| 2006 Q4 | -134 Million USD | -139.64% |
| 2006 Q3 | 338 Million USD | -49.33% |
| 2006 Q2 | 667 Million USD | -6.58% |
| 2005 Q1 | 533 Million USD | 283.45% |
| 2005 Q4 | 499 Million USD | -48.24% |
| 2005 Q3 | 964 Million USD | -3.98% |
| 2005 FY | 3 Billion USD | 25.63% |
| 2005 Q2 | 1 Billion USD | 88.37% |
| 2004 Q4 | 139 Million USD | -81.66% |
| 2004 Q3 | 758 Million USD | 43.83% |
| 2004 Q2 | 527 Million USD | -45.33% |
| 2004 Q1 | 964 Million USD | 65.35% |
| 2004 FY | 2.38 Billion USD | -23.12% |
| 2003 Q2 | 878 Million USD | 15.37% |
| 2003 FY | 3.1 Billion USD | 50.34% |
| 2003 Q4 | 583 Million USD | -34.05% |
| 2003 Q3 | 884 Million USD | 0.68% |
| 2003 Q1 | 761 Million USD | 103.48% |
| 2002 Q4 | 374 Million USD | 4.76% |
| 2002 Q3 | 357 Million USD | -18.86% |
| 2002 Q2 | 440 Million USD | -24.79% |
| 2002 Q1 | 585 Million USD | -60.01% |
| 2002 FY | 2.06 Billion USD | -60.61% |
| 2001 FY | 5.24 Billion USD | 11.34% |
| 2001 Q4 | 1.46 Billion USD | 17.51% |
| 2001 Q3 | 1.24 Billion USD | 3.66% |
| 2001 Q2 | 1.2 Billion USD | -10.1% |
| 2001 Q1 | 1.33 Billion USD | 14.88% |
| 2000 FY | 4.71 Billion USD | 13.05% |
| 2000 Q3 | 1.23 Billion USD | 13.29% |
| 2000 Q4 | 1.16 Billion USD | -5.91% |
| 2000 Q2 | 1.09 Billion USD | -10.65% |
| 2000 Q1 | 1.22 Billion USD | 16.06% |
| 1999 Q2 | 952 Million USD | -10.69% |
| 1999 FY | 4.16 Billion USD | 32.66% |
| 1999 Q1 | 1.06 Billion USD | 158.11% |
| 1999 Q3 | 1.09 Billion USD | 15.23% |
| 1999 Q4 | 1.05 Billion USD | -4.1% |
| 1998 Q3 | 966 Million USD | 15.69% |
| 1998 Q2 | 835 Million USD | -9.92% |
| 1998 FY | 3.14 Billion USD | -2.0% |
| 1998 Q4 | 413 Million USD | -57.25% |
| 1998 Q1 | 927 Million USD | 15.59% |
| 1997 Q1 | 810 Million USD | 13.13% |
| 1997 FY | 3.2 Billion USD | 12.46% |
| 1997 Q4 | 802 Million USD | -6.2% |
| 1997 Q3 | 855 Million USD | 15.85% |
| 1997 Q2 | 738 Million USD | -8.89% |
| 1996 Q4 | 716 Million USD | -4.91% |
| 1996 Q2 | 655 Million USD | -9.78% |
| 1996 Q1 | 726 Million USD | 611.27% |
| 1996 FY | 2.85 Billion USD | 57.28% |
| 1996 Q3 | 753 Million USD | 14.96% |
| 1995 Q1 | 657 Million USD | 570.41% |
| 1995 Q4 | -142 Million USD | -120.61% |
| 1995 FY | 1.81 Billion USD | -1.63% |
| 1995 Q3 | 689 Million USD | 13.32% |
| 1995 Q2 | 608 Million USD | -7.46% |
| 1994 Q3 | 621 Million USD | 14.58% |
| 1994 Q1 | 581 Million USD | 126.95% |
| 1994 FY | 1.84 Billion USD | -5.97% |
| 1994 Q4 | 98 Million USD | -84.22% |
| 1994 Q2 | 542 Million USD | -6.71% |
| 1993 Q4 | 256 Million USD | -57.89% |
| 1993 Q2 | 521 Million USD | -9.39% |
| 1993 Q1 | 575 Million USD | 70.62% |
| 1993 FY | 1.95 Billion USD | -0.15% |
| 1993 Q3 | 608 Million USD | 16.7% |
| 1992 Q4 | 337 Million USD | -42.78% |
| 1992 Q2 | 488 Million USD | -10.95% |
| 1992 Q1 | 548 Million USD | 7.45% |
| 1992 FY | 1.96 Billion USD | -4.57% |
| 1992 Q3 | 589 Million USD | 20.7% |
| 1991 Q1 | 493 Million USD | 15.73% |
| 1991 Q4 | 510 Million USD | -9.41% |
| 1991 Q3 | 563 Million USD | 14.9% |
| 1991 FY | 2.05 Billion USD | 17.62% |
| 1991 Q2 | 490 Million USD | -0.61% |
| 1990 FY | 1.74 Billion USD | 134.0% |
| 1990 Q4 | 426 Million USD | -14.11% |
| 1990 Q1 | 409 Million USD | 0.0% |
| 1990 Q3 | 496 Million USD | 18.94% |
| 1990 Q2 | 417 Million USD | 1.96% |
| 1989 Q3 | - USD | 0.0% |
| 1989 Q1 | - USD | 0.0% |
| 1989 Q4 | - USD | 0.0% |
| 1989 FY | 747 Million USD | -40.43% |
| 1989 Q2 | - USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| AbbVie Inc. | 4.86 Billion USD | -65.022% |
| Bristol-Myers Squibb Company | 8.02 Billion USD | 0.0% |
| Johnson & Johnson | 35.15 Billion USD | 77.171% |
| Eli Lilly and Company | 5.24 Billion USD | -53.137% |
| Merck & Co., Inc. | 365 Million USD | -2098.63% |
| Novartis AG | 14.85 Billion USD | 45.96% |
| Organon & Co. | 1.02 Billion USD | -684.457% |
| Pfizer Inc. | 2.11 Billion USD | -278.716% |